학술논문

P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for individuals aged 11-45 years with intermediate and poor-risk metastatic germ cell tumours (GCTs).
Document Type
Article
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, pTPS524-TPS524, 25p
Subject
Language
ISSN
0732183X